(Q32064742)

6 July 2017

1 reference

title

Spasticity management: an overview (English)

1 reference

6 July 2017

1 reference

E M Goldstein

1

1 reference

6 July 2017

publication date

1 January 2001

1 reference

Journal of Child Neurology

6 July 2017

published in

1 reference

6 July 2017

volume

16

1 reference

6 July 2017

issue

1

1 reference

6 July 2017

page(s)

16-23

1 reference

The effects of physical therapy on cerebral palsy. A controlled trial in infants with spastic diplegia.

6 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F088307380101600104

Mechanisms of action of phenol block and botulinus toxin Type A in relieving spasticity: electrophysiologic investigation and follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380101600104

Comparison of phenol block and botulinus toxin type A in the treatment of spastic foot after stroke: a randomized, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380101600104

Botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380101600104

Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380101600104

Gait before and 10 years after rhizotomy in children with cerebral palsy spasticity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380101600104

Changes in ankle spasticity and strength following selective dorsal rhizotomy and physical therapy for spastic cerebral palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380101600104

Baclofen in the treatment of cerebral palsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380101600104

Intrathecally administered baclofen for treatment of children with spasticity of cerebral origin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380101600104

Prospective assessment of continuous intrathecal infusion of baclofen for spasticity caused by acquired brain injury: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380101600104

Treatment of cerebral origin spasticity with continuous intrathecal baclofen delivered via an implantable pump: long-term follow-up review of 18 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380101600104

The effects of intrathecally administered baclofen on function in patients with spasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380101600104

Death after acute withdrawal of intrathecal baclofen: case report and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F088307380101600104

10.1177/088307380101600104

21 January 2018

Identifiers

DOI

1 reference

6 July 2017

1 reference